Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Jackson Scott Thomas Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2023 4 Jackson Scott Thomas (Director) has filed a Form 4 on MACROGENICS INC
Txns: Granted 19,000 options to buy @ $4.67, valued at $88.7k
Granted 4,500 restricted stock units @ $0
09/19/2022 4 Jackson Scott Thomas (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 15,000 shares @ $0
05/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2021 4 Jackson Scott Thomas (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 7,500 options to buy @ $13.69, valued at $102.7k
05/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/27/2020 4 Jackson Scott Thomas (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 7,500 options to buy @ $13.52, valued at $101.4k
06/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2020 4 Jackson Scott Thomas (Director) has filed a Form 4 on GLYCOMIMETICS INC
Txns: Granted 21,000 options to buy @ $3, valued at $63k
05/15/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/23/2020 3 Jackson Scott Thomas (Director) has filed a Form 3 on Spero Therapeutics, Inc.
05/21/2019 4 Jackson Scott Thomas (Director) has filed a Form 4 on GLYCOMIMETICS INC
Txns: Granted 21,000 options to buy @ $12.39, valued at $260.2k
05/20/2019 4 Jackson Scott Thomas (Director) has filed a Form 4 on MACROGENICS INC
Txns: Granted 10,000 options to buy @ $18, valued at $180k
11/28/2018 4 Jackson Scott Thomas (Director) has filed a Form 4 on GLYCOMIMETICS INC
Txns: Granted 22,000 options to buy @ $11.52, valued at $253.4k
11/28/2018 3 Jackson Scott Thomas (Director) has filed a Form 3 on GLYCOMIMETICS INC
05/21/2018 4 Jackson Scott Thomas (Director) has filed a Form 4 on MACROGENICS INC
Txns: Granted 10,000 options to buy @ $21.34, valued at $213.4k
05/22/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/25/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/25/2017 3 Form 3 - Initial statement of beneficial ownership of securities
07/12/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
07/07/2016 4 Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc
Txns: Exercised 38,135 options to buy @ $3.37, valued at $128.5k
Exercised 117,064 options to buy @ $2.44, valued at $285.6k
Exercised 96,276 options to buy @ $3.116, valued at $300k
01/29/2016 4 Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc
Txns: Granted 295,000 options to buy @ $1.32, valued at $389.4k
Granted 118,835 options to buy @ $1.32, valued at $156.9k
10/07/2015 4 Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc
Txns: Bought 14,450 shares @ $1.74, valued at $25.1k
02/27/2015 4 Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc
Txns: Granted 22,593 shares @ $0
Granted 175,000 options to buy @ $2.79, valued at $488.3k
11/18/2014 4 Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc
Txns: Bought 10,000 shares @ $2.2, valued at $22k
02/20/2014 4 Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc
Txns: Granted 157,000 options to buy @ $3.22, valued at $505.5k
12/17/2013 4 Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc
Txns: Bought 3,000 shares @ $3.4968, valued at $10.5k
08/27/2013 4 Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc
Txns: Granted 430,000 options to buy @ $3.116, valued at $1.3M
01/14/2013 3 Form 3 - Initial statement of beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy